Search

everythinglearnresearchcommunity

for

Search:↓

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Key proteins and potential drugs for treating alopecia areata were identified.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

GABRA2 gene variations impact alcohol response, and hair loss medication finasteride reduces some effects.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

Baricitinib significantly improves nail and hair symptoms in severe alopecia areata.

Hair can be used to measure cancer-related chemicals noninvasively.

Methamphetamine affects gene expression in rat whisker follicles, with key genes linked to addiction.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

A new treatment using a DNA aptamer can promote hair growth by targeting a specific receptor.

A brain-made hormone can protect against memory-related brain damage caused by harmful proteins.

New therapies for alopecia areata show potential but need more research.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

The combination therapy may be more effective for mild alopecia areata, especially in patients with allergies.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

5α-reduced neurosteroids may help regulate glial cell differentiation.

Nk-EE may help treat hair loss by promoting hair growth and preventing hair follicle damage.

The new delivery system improves Alzheimer's symptoms by releasing Huperzine A slowly and effectively.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

NGF-modified hair follicle stem cells may help treat Alzheimer's by improving brain function and reducing harmful proteins.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

Atopic dermatitis patients have much higher acetylcholine levels in their skin, which may cause itching.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Benzothiazepines like diltiazem reduce anxiety in mice by making neurosteroids.